Literature DB >> 32399017

An Association of Varicella Zoster Virus, Facial Palsy, and Meningitis in a Young Immunocompetent Male.

Amr Ashour1, Khaldun Obeidat1, Bahjat Azrieh1, Arwa Alsaud1, Mohamed Yassin1.   

Abstract

Varicella zoster is a secondary infection caused by the virus of chickenpox, after becoming latent in neurons of dorsal root ganglia or trigeminal ganglia. Varicella zoster virus (VZV) can be reactivated years later to produce shingles (zoster), generally in immunocompromised adults to produce neurological deficits and rash. Meningeal involvement of VZV is also reported and can be diagnosed. Herein, we report a 39-year-old immunocompetent male adult with a rare manifestation caused by VZV. The report is an association between facial nerve palsy and a polymerase chain reaction-confirmed VZV meningitis, even without the dermal typical rash. The patient eventually recovered after receiving acyclovir intravenously.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Cerebrospinal fluid; Cranial nerve palsy; Shingles; Varicella zoster virus

Year:  2020        PMID: 32399017      PMCID: PMC7204867          DOI: 10.1159/000506192

Source DB:  PubMed          Journal:  Case Rep Neurol        ISSN: 1662-680X


Introduction

Varicella, also commonly termed “chickenpox,” is an acute and highly contagious disease. It is caused by a primary infection with the varicella zoster virus (VZV). Varicella occurs throughout the world, especially in the absence of a routine vaccination program, and typically affects persons by mid-adulthood. The epidemiology of the disease may relate to the properties of VZV (known to be sensitive to heat, climate, population density, and risk of exposure). Following infection, the virus remains latent in nerve cells and may be reactivated causing a secondary infection, herpes zoster, commonly referred to as “shingles.” This generally occurs in adults aged over 50 years or in the immunocompromised and is usually associated with a painful rash that may result in permanent spinal nerve damage [1]. VZV may also affect the cranial nerves. Involvement of the trigeminal nerve may cause visual impairment up to blindness (herpes zoster opthalmicus), while involvement of the facial and vestibulocochlear nerves can cause facial paralysis and hearing loss (herpes zoster oticus). These presentations, in particular, require urgent medical attention to prevent serious complications [2]. Infections with neurotropic herpes viruses (such as varicella zoster virus) are frequent in humans. These viruses persist most commonly within cranial nerves, dorsal roots, and autonomic ganglia, causing latent infections with the ability of reactivation [3]. VZV infection of the central nervous system such as encephalitis, meningitis, or myelitis occurs less frequently but is feared because of the numerous unfavorable outcomes [4]. In VZV-associated meningitis, cerebrospinal fluid (CSF) analysis, polymerase chain reaction (PCR), and detection of intrathecal synthesis of antibodies are used to diagnose VZV meningitis [5]. Successful antiviral treatment has been proven by clinical and CSF follow-up examinations [6].

Case Report

A 39-year-old Bangladeshi gentleman, with no known previous medical illness, presented with a complaint of left-sided facial weakness for 2 days. Two weeks prior to admission, the patient complained of fever, headache, and sore throat. For the previous complaints, he sought medical advice in the health center. He was given some medications there, saying it was an ulcer, but his symptoms did not improve. After 1 week of the initial symptoms, the patient developed severe left-sided ear pain and tinnitus which was associated with vomiting (3–4 times per day) and dizziness. His symptoms gradually worsened. He then visited a private clinic and was prescribed antibiotics for 5 days. After taking the antibiotics for 3 days, the patient noticed weakness on the left side of his face for which he presented to the emergency department. Upon admission, the patient was complaining of headache, fever, blurring of vision, ear pain, tinnitus, ear wax discharge, hoarseness of voice, and dysphagia to solids. Detailed physical examination showed facial asymmetry (left 7th nerve upper motor neuron type) and an impairment in the left eye abduction (abducens nerve palsy); other cranial nerves were intact. An important point to note is that there was no rash in his face, throat, or in his ear canal. An urgent head CT scan was done which showed no definite acute intracranial hemorrhage or midline shift or masses. Lumber puncture was safely performed after that. The CSF specimen showed a lymphocytic viral meningitis picture, and VZV PCR was positive. Head MRI confirmed the presence of left facial nerve neuritis as well, and the patient was started on intravenous acyclovir 10 mg/kg every 8 h, along with prednisolone for possible Ramsey-Hunt syndrome. He improved gradually and eventually became asymptomatic.

Discussion

VZV central nervous system infection can have various presentations, including encephalitis, meningitis, cranial neuropathies, vasculopathy, and myelitis [7]. For example, VZV has been identified as accounting for 15–23% of viral encephalitis in the USA [8]. However, one of the extraordinary points in this case is the presence of facial palsy (considering clinical presentation and MRI images) in association with confirmed meningitis through detecting VZV chains in the CSF. Another striking point is that the absence of a rash or history of shingles does not exclude the possibility of VZV meningitis or cranial nerve involvement [9]. This makes identifying VZV as the etiology of central nervous system involvement challenging, especially in the setting of no preceding rash. Nevertheless, a rapid and accurate diagnosis is paramount as early initiation of antivirals is likely to improve patient outcomes [10]. Our case highlights an important phenomenon of whether we can always rely on the hypothesis of the presence of immunocompromising factors in VZV various infections. The abovementioned patient was an immunocompetent healthy adult with no known major illnesses. The literature reports few cases of fulminant disseminated involvement of varicella in young immunocompetent adults who developed hepatitis, severe pneumonia, rhabdomyolysis, and disseminated intravascular coagulation, followed by encephalopathy and multiorgan failure [11]. Early administration of acyclovir-prednisone was proven to reduce nerve degeneration by nerve excitability testing. Hearing recovery also tended to be better in patients with early treatment [12]. A multicenter, randomized, placebo-controlled study showed that valacyclovir and prednisolone therapy was more effective in treating Bell's palsy (excluding zoster sine herpete) than the conventional prednisolone therapy [13].

Conclusion

In conclusion, we advise physicians to consider VZV infection as a deferential diagnosis in a patient presenting with cranial nerve involvement and symptoms or signs of meningitis. Clinical suspicion of VZV cannot be ruled out, either due to the absence of features of dermal irritation such as rash or in a young and previously healthy immunocompetent patient. We think that the various clinical presentations of VZV cases are underestimated, and detailed CSF diagnostic procedures such as lumber puncture should be considered to detect the virus through PCR or intrathecal synthesis of antiviral antibodies. Treating effectively with valacyclovir and prednisolone is advised as early as possible.

Statement of Ethics

This article was approved by Hamad Medical Corporation Medical Research Center. This research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. The subject in this paper gave their informed consent to publish their case.

Disclosure Statement

The authors have no conflicts of interest to disclose.

Funding Sources

This article was funded by Qatar National Library.

Author Contributions

Amr Ashour: writing the manuscript. Khaldun Obeidat, Bahjat Azrieh, and Arwa Alsaud: clinical management. Mohamed Yassin: writing and editing.
  11 in total

Review 1.  Recommendations for the management of herpes zoster.

Authors:  Robert H Dworkin; Robert W Johnson; Judith Breuer; John W Gnann; Myron J Levin; Miroslav Backonja; Robert F Betts; Anne A Gershon; Maija L Haanpaa; Michael W McKendrick; Turo J Nurmikko; Anne Louise Oaklander; Michael N Oxman; Deborah Pavan-Langston; Karin L Petersen; Michael C Rowbotham; Kenneth E Schmader; Brett R Stacey; Stephen K Tyring; Albert J M van Wijck; Mark S Wallace; Sawko W Wassilew; Richard J Whitley
Journal:  Clin Infect Dis       Date:  2007-01-01       Impact factor: 9.079

2.  Disseminated varicella with multiorgan failure in an immunocompetent adult.

Authors:  Agnès Beby-Defaux; Séverine Brabant; Delphine Chatellier; Anne Bourgoin; René Robert; Tobias Ruckes; Gérard Agius
Journal:  J Med Virol       Date:  2009-04       Impact factor: 2.327

Review 3.  Neurological disease produced by varicella zoster virus reactivation without rash.

Authors:  Don Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

4.  Treatment of Ramsay Hunt syndrome with acyclovir-prednisone: significance of early diagnosis and treatment.

Authors:  S Murakami; N Hato; J Horiuchi; N Honda; K Gyo; N Yanagihara
Journal:  Ann Neurol       Date:  1997-03       Impact factor: 10.422

5.  Meningitis and Ramsay-Hunt syndrome in a 17-year old girl.

Authors:  Carlo Bienkowski; Monika Kowalczyk; Ewa Talarek; Maria Pokorska-Spiewak; Biruta Kierdaszuk; Magdalena Marczynska
Journal:  Neuro Endocrinol Lett       Date:  2019-11       Impact factor: 0.765

6.  The spectrum of acute encephalitis: causes, management, and predictors of outcome.

Authors:  Tarun D Singh; Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Neurology       Date:  2014-12-24       Impact factor: 9.910

7.  Results of a multinational study suggest the need for rapid diagnosis and early antiviral treatment at the onset of herpetic meningoencephalitis.

Authors:  Hakan Erdem; Yasemin Cag; Derya Ozturk-Engin; Sylviane Defres; Selcuk Kaya; Lykke Larsen; Mario Poljak; Bruno Barsic; Xavier Argemi; Signe Maj Sørensen; Anne Lisbeth Bohr; Pierre Tattevin; Jesper Damsgaard Gunst; Lenka Baštáková; Matjaž Jereb; Isik Somuncu Johansen; Oguz Karabay; Abdullah Umut Pekok; Oguz Resat Sipahi; Mahtab Chehri; Guillaume Beraud; Ghaydaa Shehata; Rosa Fontana Del Vecchio; Mauro Maresca; Hasan Karsen; Gonul Sengoz; Mustafa Sunbul; Gulden Yilmaz; Hava Yilmaz; Ahmad Sharif-Yakan; Souha Shararah Kanj; Emine Parlak; Filiz Pehlivanoglu; Fatime Korkmaz; Suheyla Komur; Sukran Kose; Mehmet Ulug; Sibel Bolukcu; Seher Ayten Coskuner; Nevin Ince; Yasemin Akkoyunlu; Gulistan Halac; Elif Sahin-Horasan; Hulya Tireli; Gamze Kilicoglu; Akram Al-Mahdawi; Salih Atakan Nemli; Asuman Inan; Seniha Senbayrak; Jean Paul Stahl; Haluk Vahaboglu
Journal:  Antimicrob Agents Chemother       Date:  2015-03-16       Impact factor: 5.191

8.  Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system.

Authors:  S M Gregoire; V van Pesch; S Goffette; A Peeters; C J M Sindic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-25       Impact factor: 10.154

9.  Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study.

Authors:  Naohito Hato; Hiroyuki Yamada; Hisashi Kohno; Shuichi Matsumoto; Nobumitsu Honda; Kiyofumi Gyo; Satoshi Fukuda; Yasushi Furuta; Fumio Ohtani; Hiroshi Aizawa; Masaru Aoyagi; Hiroo Inamura; Tsutomu Nakashima; Seiichi Nakata; Shingo Murakami; Jun Kiguchi; Koji Yamano; Taizo Takeda; Masashi Hamada; Kazuhiro Yamakawa
Journal:  Otol Neurotol       Date:  2007-04       Impact factor: 2.311

10.  Meningitis with polymerase chain reaction for varicella zoster positivity in cerebrospinal flid of a young immunocompetent adult.

Authors:  Pooja Gupta; Rajeev Ranjan; C S Agrawal; K Muralikrishnan; Nikhil Dave; Davinder Singh Rana
Journal:  J Neurosci Rural Pract       Date:  2016 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.